Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Eicosapentaenoic Acid and Central Nervous System Stimulants

Research Papers that Mention the Interaction

We conclude that EPA reduces plasma large, light LDL levels as well as plasma VLDL amounts and stimulates LTP activities.
Atherosclerosis  •  1991  |  View Paper
We have previously reported that eicosapentaenoic acid (EPA; 20:5, n-3) pretreatment stimulates migration of ECs but not smooth muscle cells.
Prostaglandins, leukotrienes, and essential fatty acids  •  1996  |  View Paper
Results from the present study suggest that dietary EPA might stimulate the plasma lipoprotein metabolism and also alter lipogenesis in the liver of SHRSP rats.
Atherosclerosis  •  1994  |  View Paper
There is evidence from past studies that new IPA entrants can stimulate the price competition desired by health care reformers.
Managed care quarterly  •  1993  |  View Paper